DCN Dx
Founded in 2005, DCN is a contract developer and manufacturer of rapid point of care diagnostic tests. The company’s core expertise is lateral flow immunoassay development.
Investment Rationale
- Opportunity to build an integrated CDMO offering
- High-growth core market with opportunity for expansion into adjacent areas
- Market leading brand in the POC diagnostics industry
Key Value Add Areas
- Team & Board
- Strategic Planning
- M&A
- Monitoring & Reporting
Headquarters:
Carlsbad, CA
Website:
Investment Date:
Nov 2020
Sector:
Products & Diagnostics
Status:
Current